Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Amanda Sealy"


5 mentions found


CNN —Zepbound, a popular weight loss drug, also seems to help people with obstructive sleep apnea, drugmaker Eli Lilly said Wednesday. Based on results from trials in people with sleep apnea, the company said it plans to submit the material to the US Food and Drug Administration to potentially expand the use of Zepbound for obstructive sleep apnea. Obstructive sleep apnea is a disorder that causes people to briefly stop breathing while they are sleeping, sometimes several times an hour. While people are more at risk for obstructive sleep apnea as they get older, it often develops when people gain weight and have overweight or obesity. Some doctors have been prescribing the weekly injection off label to people with obstructive sleep apnea, and Lilly has been testing the drug for obstructive sleep apnea since June 2022.
Persons: CNN —, Eli Lilly, Lilly, didn’t, Dr, Sanjay Gupta, CNN’s Meg Tirrell, Amanda Sealy Organizations: CNN, Food and Drug Administration, World Health, US Food and Drug Administration, CNN Health, American Diabetes Association
Without ever clicking a mouse or touching a screen, Mark selected this command on his computer simply using signals from his brain. “I figured I had two choices: I could wallow in self-pity, or I could pick myself up by the bootstraps and do what I could to help,” Mark said. Synchron’s brain implant, the one Mark has, is called a Stentrode and consists of a stent with electrode sensors that can detect electrical brain activity. That external transmitter sits right above the internal transmitter and carries the signal from Mark’s brain to the computer almost instantaneously. Earlier this month, Musk also said Neuralink’s first human trial participant can control a computer mouse with their brain.
Persons: Sanjay Gupta’s, Erin Burnett OutFront, CNN —, Mark, Lou Gehrig’s, ” Mark, Elon Musk, , , Sanjay Gupta, Synchron, Tom Oxley, hardwired, he’s, Mark didn’t, “ We’d, Maria Nardozzi, ” Oxley, CNN Mark, Musk’s Neuralink, Oxley, António Guterres, ” Elon Musk, Gonzalo Fuentes, Neuralink, Musk, Hope Organizations: CNN, BCI, US Food and Drug Administration, Netflix, US Securities and Exchange Commission, United Nations, Reuters, SpaceX Locations: Neuralink, UNESCO’s, Pennsylvania
CNN —As cases of salmonella infections linked to recalled charcuterie meats double, the US Centers of Disease Control and Prevention expanded its warning in a new food safety alert on Thursday. That’s almost double the cases from the last update on January 5th where 24 illnesses and five hospitalizations had been reported in 14 states. The CDC cautions that the true number of illnesses is most likely higher and could also be in present in other states. The warning is now also being expanded beyond one specific lot number of Busseto brand Charcuterie Sampler. Fratelli Beretta recalled more than 11,000 pounds of the charcuterie meat products earlier this month, but only one specific lot code.
Persons: That’s, Fratelli Beretta, Gran Beretta, It’s Organizations: CNN, US Centers of Disease Control, CDC, Costco Locations: Arizona , Colorado , Connecticut , Idaho , Illinois , Kentucky, Maryland , Michigan, Minnesota , Missouri , Nebraska , New Jersey , New York , Ohio , Oregon , Pennsylvania, Texas , Utah, Virginia , Vermont, Washington and Wisconsin
CNN —Measles vaccination rates dropped throughout the pandemic and hit the lowest coverage rate in more than a decade, says a new study published by the US Centers for Disease Control and Prevention. Although global measles vaccinations mostly improved from 2000 to 2021, the Covid-19 pandemic presented a setback in the efforts to eliminate the disease, according to the study published Wednesday. The researchers say this is the lowest coverage rate since 2008. The researchers say that “an estimated 56 million measles deaths were averted by vaccination.”The data comes from 194 World Health Organization member states from six regions that have committed to eliminating measles. “All WHO regions remain committed to measles elimination; however, no region has achieved and sustained elimination targets,” the researchers wrote.
CNN —A monoclonal antibody treatment for Alzheimer’s disease called lecanemab slows the progression of cognitive decline by 27% compared with a placebo, drugmakers Biogen and Eisai said Tuesday. Alzheimer’s is a very heterogeneous disease.”But he says that does not diminish the potential significance of the trial. “In the past, reducing amyloid in the brain has not always been tied to cognitive improvements or any meaningful clinical improvements. Biogen is also the company behind another Alzheimer’s drug, Aduhelm, which was controversially approved by the FDA in June 2021. Aduhelm was the first new Alzheimer’s drug approved in nearly 20 years, but there were questions about its efficacy and cost.
Total: 5